A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer

NCT05170594 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Bevacizumab
DRUG: chemotherapy
DRUG: Fluzoparib

Sponsor

The Second Affiliated Hospital of Shandong First Medical University